Mirum Pharmaceuticals (MIRM) Inventory (2021 - 2026)

Mirum Pharmaceuticals' Inventory history runs 6 years deep, the most recent figure standing at $25.5 million for Q1 2026.

• In Q1 2026, Inventory rose 13.83% year-over-year to $25.5 million; the TTM figure through Mar 2026 stood at $25.5 million (up 13.83% YoY), while the FY2025 annual figure was $24.9 million, up 11.09% from the prior year.
• Inventory was $25.5 million for Q1 2026 at Mirum Pharmaceuticals, up from $24.9 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $25.5 million in Q1 2026 to a low of $1.6 million in Q1 2022.
• Historically, Inventory has averaged $16.7 million across 5 years, with a median of $21.6 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Inventory soared 318.54% in 2023, then declined 2.95% in 2024.
• A 5-year view of Inventory shows it stood at $5.6 million in 2022, then soared by 300.93% to $22.3 million in 2023, then rose by 0.41% to $22.4 million in 2024, then grew by 11.09% to $24.9 million in 2025, then increased by 2.54% to $25.5 million in 2026.
• The last three Inventory figures came in at $25.5 million (Q1 2026), $24.9 million (Q4 2025), and $24.0 million (Q3 2025), per Business Quant data.